Medsenic
Trending Articles
Related Content
Research & Development
Medsenic raises €2m and improves its development capacities
The new funds will allow the company to pursue its research on arsenic trioxide and continue its promising clinical trials for autoimmune diseases, such as severe Systemic Lupus Erythematosus and Graft-versus-Host Disease (GvHD)